Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 21 studies | 27% ± 12% | |
mesothelial cell | 10 studies | 48% ± 23% | |
endothelial cell of artery | 7 studies | 34% ± 18% | |
Mueller cell | 6 studies | 55% ± 14% | |
connective tissue cell | 5 studies | 36% ± 15% | |
smooth muscle cell | 5 studies | 21% ± 4% | |
GABAergic neuron | 4 studies | 27% ± 7% | |
podocyte | 4 studies | 42% ± 16% | |
endothelial cell | 4 studies | 37% ± 17% | |
retinal pigment epithelial cell | 3 studies | 50% ± 24% | |
adventitial cell | 3 studies | 22% ± 2% | |
astrocyte | 3 studies | 28% ± 16% |
Insufficient scRNA-seq data for expression of SULF1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 85% | 2680.31 | 390 / 459 | 95% | 121.73 | 1064 / 1118 |
prostate | 96% | 7850.32 | 235 / 245 | 75% | 32.66 | 375 / 502 |
thymus | 99% | 6229.26 | 645 / 653 | 69% | 34.85 | 416 / 605 |
intestine | 83% | 7458.14 | 804 / 966 | 80% | 77.20 | 424 / 527 |
lung | 72% | 2035.36 | 416 / 578 | 87% | 72.67 | 1001 / 1155 |
esophagus | 75% | 3008.27 | 1081 / 1445 | 77% | 62.23 | 140 / 183 |
uterus | 90% | 4845.16 | 153 / 170 | 58% | 38.45 | 265 / 459 |
kidney | 80% | 2437.07 | 71 / 89 | 60% | 34.65 | 537 / 901 |
ovary | 72% | 2119.32 | 130 / 180 | 67% | 46.54 | 286 / 430 |
bladder | 62% | 2370.57 | 13 / 21 | 63% | 49.55 | 317 / 504 |
stomach | 30% | 758.44 | 108 / 359 | 83% | 81.00 | 238 / 286 |
blood vessel | 100% | 23804.65 | 1335 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 2% | 69.34 | 8 / 328 | 89% | 154.24 | 159 / 178 |
adipose | 89% | 5419.02 | 1072 / 1204 | 0% | 0 | 0 / 0 |
skin | 37% | 4373.23 | 665 / 1809 | 49% | 28.95 | 230 / 472 |
tonsil | 0% | 0 | 0 / 0 | 62% | 35.07 | 28 / 45 |
heart | 51% | 1629.81 | 442 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 21.18 | 14 / 29 |
brain | 8% | 152.13 | 204 / 2642 | 36% | 16.14 | 252 / 705 |
adrenal gland | 2% | 54.79 | 6 / 258 | 18% | 5.41 | 42 / 230 |
liver | 0% | 7.38 | 1 / 226 | 18% | 7.02 | 74 / 406 |
eye | 0% | 0 | 0 / 0 | 4% | 1.46 | 3 / 80 |
muscle | 3% | 75.25 | 28 / 803 | 0% | 0 | 0 / 0 |
spleen | 1% | 25.28 | 3 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 14.21 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0003094 | Biological process | glomerular filtration |
GO_0035860 | Biological process | glial cell-derived neurotrophic factor receptor signaling pathway |
GO_0014846 | Biological process | esophagus smooth muscle contraction |
GO_0001822 | Biological process | kidney development |
GO_0032836 | Biological process | glomerular basement membrane development |
GO_0030201 | Biological process | heparan sulfate proteoglycan metabolic process |
GO_0002063 | Biological process | chondrocyte development |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0001937 | Biological process | negative regulation of endothelial cell proliferation |
GO_0048706 | Biological process | embryonic skeletal system development |
GO_0030513 | Biological process | positive regulation of BMP signaling pathway |
GO_0060686 | Biological process | negative regulation of prostatic bud formation |
GO_0010575 | Biological process | positive regulation of vascular endothelial growth factor production |
GO_0006915 | Biological process | apoptotic process |
GO_0048010 | Biological process | vascular endothelial growth factor receptor signaling pathway |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0040036 | Biological process | regulation of fibroblast growth factor receptor signaling pathway |
GO_0060348 | Biological process | bone development |
GO_0060384 | Biological process | innervation |
GO_0051216 | Biological process | cartilage development |
GO_0040037 | Biological process | negative regulation of fibroblast growth factor receptor signaling pathway |
GO_0030177 | Biological process | positive regulation of Wnt signaling pathway |
GO_0005795 | Cellular component | Golgi stack |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0009986 | Cellular component | cell surface |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0004065 | Molecular function | arylsulfatase activity |
GO_0005539 | Molecular function | glycosaminoglycan binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0008449 | Molecular function | N-acetylglucosamine-6-sulfatase activity |
Gene name | SULF1 |
Protein name | Sulfatase 1 SULF1 protein Extracellular sulfatase Sulf-1 (hSulf-1) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form] |
Synonyms | KIAA1077 |
Description | FUNCTION: Exhibits arylsulfatase activity and highly specific endoglucosamine-6-sulfatase activity . It can remove sulfate from the C-6 position of glucosamine within specific subregions of intact heparin . Diminishes HSPG (heparan sulfate proteoglycans) sulfation, inhibits signaling by heparin-dependent growth factors, diminishes proliferation, and facilitates apoptosis in response to exogenous stimulation . . |
Accessions | ENST00000534179.5 E9PLS5 Q96E28 E9PS14 ENST00000528783.5 ENST00000525999.5 ENST00000616868.1 A0A087WWR8 ENST00000529134.5 Q8IWU6 H0YDR1 ENST00000419716.7 ENST00000402687.9 ENST00000525061.5 E9PJL8 ENST00000531512.5 E9PI06 ENST00000458141.6 Q6NUJ9 ENST00000260128.8 E9PPQ3 |